Press Releases

Date Title View
Toggle Summary Second Sight Reports First Quarter 2015 Financial Results
SYLMAR, Calif. --(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide functional vision to blind patients, today reported financial results for the three-month
View HTML
Toggle Summary Second Sight Announces Exclusive Agreement With Gulf Medical Company to Distribute the Argus II Retinal Prosthesis System in Saudi Arabia
SYLMAR, Calif. , May 7, 2015 (GLOBE NEWSWIRE) -- Second Sight Medical Products, Inc. ("Second Sight" or "the Company") (Nasdaq:EYES), a developer, manufacturer and marketer of implantable visual prosthetics to restore some useful vision to blind patients, has signed an exclusive agreement with Gulf
View HTML
Toggle Summary Second Sight Announces Senior Management Appointments in Commercialization and Manufacturing
SYLMAR, Calif. --(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to restore functional vision to blind patients, today announced two senior management appointments in
View HTML
Toggle Summary Second Sight to Discuss 2015 First Quarter Financial Results on May 13, 2015 Conference Call
SYLMAR, Calif. --(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) will release its 2015 first quarter results on Wednesday, May 13, 2015 , after the close of the U.S. financial markets. Dr. Robert Greenberg , President and Chief Executive Officer, and Tom Miller , Chief Financial
View HTML
Toggle Summary Second Sight Announces First Successful Implant of Model of Orion I Visual Cortical Prosthesis
SYLMAR, Calif., April 8, 2015 (GLOBE NEWSWIRE) -- Second Sight Medical Products, Inc. (Nasdaq:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to restore functional vision to blind patients, today announced the first successful
View HTML
Toggle Summary Second Sight Reports Fourth Quarter and Year End 2014 Financial Results and Provides Business Update
SYLMAR, Calif. --(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a leading developer, manufacturer and marketer of implantable visual prosthetics to provide functional vision to blind patients, today reported financial results for the three-
View HTML
Toggle Summary Second Sight Announces Successful First Implants of the Argus® II Retinal Prosthesis System at Two New Centers in Italy
SYLMAR, Calif. --(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (Nasdaq: EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide functional vision to blind patients, today announced that two newly approved centers, located
View HTML
Toggle Summary Second Sight to Discuss Fourth Quarter and Year-End 2014 Financial Results on March 11, 2015 Conference Call
SYLMAR, Calif. --(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) will release its 2014 fourth quarter and year-end financial results on Wednesday, March 11, 2015 , after the close of the U.S. financial markets. Dr. Robert Greenberg , President and Chief Executive Officer, and
View HTML
Toggle Summary Second Sight Announces First Commercial Implants of the Argus® II Retinal Prosthesis System in France
SYLMAR, Calif. --(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (Nasdaq:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide functional vision to blind patients, today announced that all three of the centers approved to
View HTML
Toggle Summary Second Sight to Present at the 27th Annual ROTH Conference on March 9, 2015
SYLMAR, Calif. --(BUSINESS WIRE)-- Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics to provide functional vision to blind patients, today announced that Dr.
View HTML